NCT02378129

Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements

Evaluation of the Effectiveness of Dentin Hypersensitivity Treatment Using Glass Ionomer Cements: A Randomized Clinical Trial

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Federal University of Pelotas · Academic / Other
• Sex: All
• Age: 28 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.

Detailed description

Subjects will require to have at least two teeth in different hemiarchs with dentin hypersensitivity. Teeth will be randomized into 2 groups, receiving either Clinpro XT or the conventional glass ionomer cement Vidrion R. Prior to the desensitizing treatment (baseline), painful symptoms will be assessed by tactile and air blast tests using the Visual Analogue Scale (VAS). Treatment evaluations will be conducted up to 2-year post-treatment.

Conditions

• Dentin Hypersensitivity

Interventions

Type	Name	Description
DRUG	Resin-modified glass ionomer cement Clinpro XT	Clinpro XT (3M ESPE, Minnesota, USA)
DRUG	Glass Ionomer cement Vidrion R	Vidrion R (SS White, Gloucester, UK)

Timeline

• Start date: 2014-04-02
• Primary completion: 2015-04-01
• Completion: 2015-04-01
• First posted: 2015-03-04
• Last updated: 2020-08-17